Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

ITP is usually a chronic condition in adults resulting from both platelet destruction and impaired production. This study summarizes the early phase experience in two trials for chronic refractory ITP of AMG 531, a novel thrombopoiesis stimulating protein.

AMG 531 Promotes Thrombopoiesis in ITP